Anal Canal Cancer: A Population-Based Reappraisal

Diseases of the Colon and Rectum

Volumn 46, Issue 11, 2003, Pages 1517-1523

  Maggard, Melinda A ^a   Beanes, Steven R ^a   Ko, Clifford Y ^a,b   Northover, John ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHS ^*

Author keywords

Anal canal cancer; Incidence rates; Racial ethnic disparities; Survival

Indexed keywords

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DEMOGRAPHY; ETHNOLOGY; FEMALE; HUMAN; MALE; RACE;

EID: 0242594536     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6806-8     Document Type: Article

References (28)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 2000;50:7-33.
2. Stearns MW, Urmacher C, Sternberg SS. Cancer of the anal canal. Curr Probl Cancer 1980;4:1-44.
3. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800.
4. Licitra L, Spinazzi S, Doci R, Evans TR, Tanum G, Ducreux M. Cancer of the anal region. Crit Rev Oncol Hematol 2002;43:77-92.
5. Esiashvili N, Landry J, Matthews RH. Carcinoma of the anus: strategies in management. Oncologist 2002;7:188-99.
6. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002;9:86-91.
7. O'Meara AT. Present standards for cervical cancer screening. Curr Opin Oncol 2002;14:505-11.
8. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
9. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-6.
10. Sischy B, Remington JH, Hinson EJ, Sobel SH, Woll JE. Definitive treatment of anal-canal carcinoma by means of radiation therapy and chemotherapy. Dis Colon Rectum 1982;25:685-8.
11. Meeker WR Jr, Sickle-Santanello BJ, Philpott G, et al. Combined chemotherapy, radiation and surgery for epithelial cancer of the anal canal. Cancer 1986;57:525-9.
12. Doci R, Zucali R, Bombelli L, et al. Combined chemoradiation therapy for anal cancer: a report of 56 cases. Ann Surg 1992;215:150-6.
13. Johnson D, Lipsett J, Leong L, Wagman LD, Terz JJ. Carcinoma of the anus treated with primary radiation therapy and chemotherapy. Surg Gynecol Obstet 1993;177:329-34.
14. Fung CY, Willett CG, Efird JT, et al. Chemoradiation for anal carcinoma: what is the optimal radiation dose? Radiat Oncol Invest 1994;2:152-6.
15. John M, Flam M, Palma N. Ten-year results of chemoradiation for anal cancer: focus on late morbidity. Int J Radiat Oncol Biol Phys 1996;34:65-9.
16. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686-93.
17. Tolmos J, Vargas HI, Lim S, Stamos M. A forty-year experience with anal carcinoma: changing trends and impact of multimodality therapy. Am Surg 1997;63:918-22.
18. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39.
19. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-54.
20. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
21. Burnley IH. Mortality from selected cancers in NSW and Sydney, Australia. Soc Sci Med 1992;35:195-208.
22. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
23. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from the NSABP protocol R-01. J Natl Cancer Inst 1988;80:20-9.
24. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. Review. J Natl Cancer Inst 2001;93:501-15.
25. Engel J, Nagel G, Breuer E, et al. Primary breast cancer therapy in six regions of Germany. Eur J Cancer 2002; 38:578-85.
26. Shah S, Doyle K, Lange EM, et al. Breast cancer recurrences in elderly patients after lumpectomy. Am Surg 2002;68:735-9.
27. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343-50.
28. Mariotto A, Capocaccia R, Verdecchia A, et al. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control 2002;13:101-11.